These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6556109)

  • 1. [Behavior of the renin-angiotensin-aldosterone system and urinary kallikrein in patients with ascitic hepatic cirrhosis].
    Aguglia F; Santucci A; De Mattia G; Gnecchi M; Trinchieri F; Giordano M; Cammarella I; Ficara C
    Clin Ter; 1983 Jul; 106(1):43-6. PubMed ID: 6556109
    [No Abstract]   [Full Text] [Related]  

  • 2. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical assessment of electrolyte metabolism and the renin-aldosterone system in patients with liver cirrhosis and ascites].
    Mansurov KhKh; Dustov AD; Nikolaeva OS
    Ter Arkh; 1989; 61(11):54-7. PubMed ID: 2699096
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of the renin-angiotensin-aldosterone system in ascitic hepatic cirrhosis. Effects of inhibition of angiotensin I converting enzyme].
    Santucci A; Aguglia F; De Mattia G; Cammarella I; Trinchieri F; Giordano M; Gnecchi M; Ficara C
    Clin Ter; 1983 Jul; 106(2):121-4. PubMed ID: 6313280
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The renin-angiotensin-aldosterone system in liver cirrhosis].
    Chmielewska J
    Przegl Lek; 1983; 40(8):619-22. PubMed ID: 6364257
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relation existing between the kallikrein-kinin and renin-angiotensin-aldosterone systems].
    Santucci A; Aguglia F; Violi F; De Mattia G; Cammarella I; Giordano M; Trinchieri F; Gnecchi M
    Clin Ter; 1983 Aug; 106(3):213-7. PubMed ID: 6354571
    [No Abstract]   [Full Text] [Related]  

  • 8. [State of the kallikreinogen-kallikrein system in patients with liver diseases].
    Paskhina TS; Bondar' ZA; Krinskaia AV; Melkumova IS; Polikarpova EG
    Klin Med (Mosk); 1975 Aug; 53(8):9-15. PubMed ID: 1186098
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion.
    La Villa G; Laffi G; Pinzani M; Pampana A; Mannelli M; Smorlesi C; Gentilini P
    Boll Soc Ital Biol Sper; 1984 Mar; 60(3):535-41. PubMed ID: 6561965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin in the ascitic fluid of patients with liver cirrhosis.
    Cugno M; Salerno F; Nussberger J; Bottasso B; Lorenzano E; Agostoni A
    Clin Sci (Lond); 2001 Dec; 101(6):651-7. PubMed ID: 11724653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the renin-aldosterone system in patients with hepatic cirrhosis during concentration-reinfusion of ascitic fluid].
    Giudici Cipriani A; Richeri F; Bonanni F; Barbetti V; Rembado R; Marenco G
    Recenti Prog Med; 1983 Dec; 74(12):1360-9. PubMed ID: 6672909
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems.
    Zipser RD; Kerlin P; Hoefs JC; Zia P; Barg A
    Am J Gastroenterol; 1981 Mar; 75(3):183-7. PubMed ID: 7015845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Our 2-year experience with the reinfusion of concentrated ascitic fluid in liver cirrhosis with emphasis on the hemodynamic effects of the renin-angiotensin-aldosterone system].
    Cervinka J; Benes R; Kordac V; Horký K
    Cas Lek Cesk; 1984 Apr; 123(16):482-4. PubMed ID: 6733746
    [No Abstract]   [Full Text] [Related]  

  • 15. [Estimation of plasma renin, angiotensin II and urinary aldosterone in patients with cirrhosis of liver and its clinical significance].
    Tang ZD
    Zhonghua Nei Ke Za Zhi; 1982 Oct; 21(10):602-4. PubMed ID: 6759071
    [No Abstract]   [Full Text] [Related]  

  • 16. [The clinical importance of determining aldosterone in the ascitic fluid].
    Maleeva A; Stanchev N; Konstantinova N; Aleksiev A
    Vutr Boles; 1990; 29(6):72-7. PubMed ID: 2091389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolactin in plasma and ascitic fluid in hepatic cirrhosis. Its relation to plasma and urinary electrolytes].
    Ostolaza Vázquez JM; Jimeno Carruez A; Lapeña Villarroyo G; Vallecillo Sande MA; Ibañes Jalón E; Almaraz Quintana C
    Rev Esp Enferm Apar Dig; 1986 Apr; 69(4):205-9. PubMed ID: 3523651
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cirrhotic ascites and the renin-angiotensin system].
    Gonvers JJ; Loup P; Hofstetter JR; Brunner HR
    Schweiz Med Wochenschr; 1980 May; 110(22):869-71. PubMed ID: 6996085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The renin-angiotensin-aldosterone system during the extraction, concentration and reinfusion of ascitic fluid in cirrhotic patients].
    Giorcelli V; Fossale PG
    Arch Sci Med (Torino); 1983; 140(3):273-80. PubMed ID: 6675585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.